Professor Huw Morris is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and Professor of Clinical Neuroscience at the UCL Institute of Neurology in Queen Square. He sees both NHS and private patients here in Queen Square. We spoke with Professor Morris to find out more about his expertise in neurology and his special interest in movement disorders.
Q: Professor Morris, thank you for taking the time to speak with us today. Firstly, would you please explain your role here in Queen Square and your particular areas of clinical expertise?
I work as a Consultant Neurologist and Professor of Clinical Neuroscience at the Institute of Neurology in Queen Square, splitting my time between clinical neurology and research. My main clinical and research interests are in movement disorders and neurogenetics.
Q: Queen Square is widely regarded as the home of neurology and contains a wide variety of skills and expertise. How important to you and your clinical practice is the ability to work alongside colleagues from other clinical specialisms?
Queen Square is unusual in having a wide range of expertise in neurology across both research and clinical practice, and across all neurological disorders. This greatly enhances the opportunities we have to offer the best care, and to develop new treatments.
Q: You have chosen to hold clinics at the Queen Square Private Consulting Rooms for private patients. Why have you chosen Queen Square for this?
The Queen Square Private Consulting Rooms are dedicated to providing care for neurological and neurosurgery patients and is very closely linked to the National Hospital here in Queen Square. This provides the opportunity to liaise with experts across neurology and the specialist neurosurgery, neuroradiology and neurophysiology services.
Q: Alongside your clinical work, you are also heavily involved in research into movement disorders. Where is the focus for this research currently?
I have carried out research in Parkinson’s Disease, Atypical Parkinsonian Disorders (such as Progressive Supranuclear Palsy, Multiple System Atrophy and Cortio-basal degeneration), Dementia and Motor Neuron Disease. Currently, I focus on Parkinson’s, particularly familial and early onset forms of Parkinson’s and atypical parkinsonian disorders. We are focussed on understanding how these disorders develop and progress and in the development of new treatments.
Q: What, in your opinion, might be on the horizon for the diagnosis and treatment of movement disorders?
We have already seen significant developments in the neurosurgical (deep brain stimulation) treatment for Parkinson’s Disease and tremor. I think in the future, there will be personalised treatment for Parkinson’s and related disorders – that is we will understand how Parkinson’s differs between individual patients and we will be able to offer specific treatments which best treat the symptoms and potentially change the disease progression.
Q: If a private patient is interested in seeing you in one of your clinics, how can they go about organising this?
Patients can contact me directly by contacting my private secretary, Katia Crowley, at firstname.lastname@example.org. Patients can also speak with the staff at the Private Consulting Rooms on 020 3448 8948.